Chinese english Germany Japanese Korea

1,7-Naphthyridine-3-carboxylic acid, 5-bromo-

1,7-Naphthyridine-3-carboxylic acid, 5-bromo- Struktur
1646882-64-5
CAS-Nr.
1646882-64-5
Englisch Name:
1,7-Naphthyridine-3-carboxylic acid, 5-bromo-
Synonyma:
1,7-Naphthyridine-3-carboxylic acid, 5-bromo-
CBNumber:
CB19750060
Summenformel:
C9H5BrN2O2
Molgewicht:
253.05
MOL-Datei:
1646882-64-5.mol
Request For Quotation

1,7-Naphthyridine-3-carboxylic acid, 5-bromo- Eigenschaften

Siedepunkt:
421.8±40.0 °C(Predicted)
Dichte
1.824±0.06 g/cm3(Predicted)
pka
2.83±0.30(Predicted)

Sicherheit

1,7-Naphthyridine-3-carboxylic acid, 5-bromo- Chemische Eigenschaften,Einsatz,Produktion Methoden

1,7-Naphthyridine-3-carboxylic acid, 5-bromo- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1,7-Naphthyridine-3-carboxylic acid, 5-bromo- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 10)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Yujinpharma(Tianjin) Technology Co.,Ltd. 13370351217 kungfu1217@1
 kungfu1217@163.com China 9573 58
Suzhou Kangrun Pharmaceutical Co., Ltd. 0512-63912376 18962555590
 China 973 58
Shanghai Haohong Pharmaceutical Co., Ltd. 4008210725 4008210725
 malulu@leyan.com China 55023 58
Bide Pharmatech Ltd. 400-1647117 15221909166
 product02@bidepharm.com China 63720 58
Bide Pharmatech Ltd. 400-6005915
sales@picasso-e.com China 39668 58
Shanghai Yanbang Pharmaceutical Technology Co., Ltd 15618536883
 1228181347@qq.com China 491 58
Beijing Solarbio Science & Tecnology Co., Ltd. 010-50973130 17801761073
 Gsiyu@solarbio.com China 50471 58
Shanghai Jieshikai Biotechnology Co. , Ltd. 021-57520305 15001810326
 guojianing@jskchem.com China 49242 58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-66113011 18112977050
 cb5@aikonchem.com China 10529 58
Guangdong Shengke Biochemical Technology Co., Ltd. 189-25112307 18925113981
 3809205144@qq.com China 10002 58
  • 1,7-Naphthyridine-3-carboxylic acid, 5-bromo-
  • 1646882-64-5
Copyright 2019 © ChemicalBook. All rights reserved